Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Eton Pharmaceuticals, Inc.
ETON
Concentration Risk %
Concentration Risk % at other companies
Burlington Stores
BURL
5%
0.0pp
Burlington Stores
BURL
0.8%
0.0pp
Ulta Beauty, Inc.
ULTA
40%
0.0pp
Ulta Beauty, Inc.
ULTA
4%
0.0pp
Ulta Beauty, Inc.
ULTA
24%
-1.0pp
Expro Group Holdings
XPRO
4.8%
+0.4pp
Other financials
Income statement
See full
Revenue
$24.3M
+40.4%
Gross profit
$14.7M
+49.4%
Operating income
$2.4M
+614%
Net income
$1.6M
+199%
EPS (diluted)
$0.05
+183%
Balance sheet
See full
Cash & equivalents
$19.7M
+12.9%
Total debt
$31.3M
+3.7%
Total equity
$30.6M
+25.2%
Total assets
$97.7M
+16.3%
Cash flow
See full
Operating cash flow
$7.4M
+254%
CapEx
$75.0K
—
Free cash flow
$7.3M
+251%
Valuation
See full
Market cap
$1.22B
+162%
Enterprise value
$1.23B
+161%
P/S
14.1×
+6.0×
Profitability
See full
Gross margin
54.8%
-3.7pp
Operating margin
-15.1%
—
Net margin
-9.5%
-2.7pp
FCF margin
17.1%
—
Returns & leverage
See full
Return on equity
-34.2%
+0.9pp
Debt / equity
1×
-0.2×
Current ratio
1.2×
-0.8×
Watchlist
Screener
Filings
Earnings
Charts